Overview

A Study to Examine the Effect of Daridorexant on the Way the Body Absorbs, Distributes, and Gets Rid of Dabigatran and Rosuvastatin in Healthy Male Subjects

Status:
Not yet recruiting

Trial end date:
2022-09-17

Target enrollment:

Participant gender:

Summary

A study to examine the effect of daridorexant on the way the body absorbs, distributes, and gets rid of dabigatran and rosuvastatin in healthy male subjects

Phase:

Phase 1

Details

Lead Sponsor:

Idorsia Pharmaceuticals Ltd.

Treatments:

Dabigatran
Rosuvastatin Calcium